semaglutide weight loss clinic walnut creek Management with Weight Loss Program | Novuskin

Critically revising the article: both authors

p = 0.002) (35)

Large BMJ Study Confirms GLP-1 Drugs Like Ozempic and Mounjaro Are Linked to a Real Hair Loss Risk A large peer-reviewed study published in the British Medical Journal on July 22, 2026, has found that adults using GLP-1 receptor agonist drugs including semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound) had a significantly higher rate of clinically recorded hair loss compared with people taking two other commonly prescribed diabetes medications

Pick IV 3

This portends the synergistic activation of the pathway when both drugs are used together

Outdated products compromise patient safety during injections